摘要
光动力学疗法(PDT)是一个新颖的治疗技术,包含以下三个主要成分:光、一个光敏剂分子和分子氧化,这些都是必需的以达到治疗的效果。通过PDT治疗许多的癌症和皮肤疾病显示出了极大的研究兴趣。通过一个特定的波长的光线照射,光敏剂经过几个反应导致活化氧的产生。活化氧可与许多不同的大分子反应,导致许多细胞结构和生物化学通路的缺陷。PDT介导的体内肿瘤破坏包括多类细胞机制:线粒体的光损伤、溶酶体、细胞核以及细胞膜,这些可以激活凋亡、坏死、吞噬信号,导致细胞的死亡。PDT能够改变肿瘤的微环境,从而减少氧的供给,这就解释了PDT的抗血管生成作用。最终,炎症和免疫反映在PDT治疗长期的影响中起到关键的作用。本综述着重于由光动力疗法在细胞死亡的信号通路中展露出的生物化学作用,脉管系统破坏以及免疫系统的激活。
关键词: 血管生成,凋亡,细胞死亡,细胞机制,免疫学,PDT机制,光动力疗法,光敏剂
Current Medicinal Chemistry
Title:Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment
Volume: 21 Issue: 35
Author(s): P. Skupin-Mrugalska, L. Sobotta, M. Kucinska, M. Murias, J. Mielcarek and N. Duzgunes
Affiliation:
关键词: 血管生成,凋亡,细胞死亡,细胞机制,免疫学,PDT机制,光动力疗法,光敏剂
摘要: Photodynamic therapy (PDT) is a novel medical technique involving three key components: light, a photosensitizer molecule and molecular oxygen, which are essential to achieve the therapeutic effect. There has been great interest in the use of PDT in the treatment of many cancers and skin disorders. Upon irradiation with light of a specific wavelength, the photosensitizer undergoes several reactions resulting in the production of reactive oxygen species (ROS). ROS may react with different biomolecules, causing defects in many cellular structures and biochemical pathways. PDT-mediated tumor destruction in vivo involves cellular mechanisms with photodamage of mitochondria, lysosomes, nuclei, and cell membranes that activate apoptotic, necrotic and autophagic signals, leading to cell death. PDT is capable of changing the tumor microenvironment, thereby diminishing the supply of oxygen, which explains the antiangiogenic effect of PDT. Finally, inflammatory and immune responses play a crucial role in the long-lasting consequences of PDT treatment. This review is focused on the biochemical effects exerted by photodynamic treatment on cell death signaling pathways, destruction of the vasculature, and the activation of the immune system.
Export Options
About this article
Cite this article as:
Skupin-Mrugalska P., Sobotta L., Kucinska M., Murias M., Mielcarek J. and Duzgunes N., Cellular Changes, Molecular Pathways and the Immune System Following Photodynamic Treatment, Current Medicinal Chemistry 2014; 21 (35) . https://dx.doi.org/10.2174/0929867321666140826120300
DOI https://dx.doi.org/10.2174/0929867321666140826120300 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Thymidine Phosphorylase and Fluoropyrimidines Efficacy: A Jekyl and Hyde Story
Current Medicinal Chemistry - Anti-Cancer Agents Medicinal and Beneficial Health Applications of Tinospora cordifolia (Guduchi): A Miraculous Herb Countering Various Diseases/Disorders and its Immunomodulatory Effects
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Fc-fusion Proteins in Therapy: An Updated View
Current Medicinal Chemistry Floating Drug Delivery Systems for Prolonging Gastric Residence Time: A Review
Current Drug Delivery CycloSal-dRFIB, a Thymidine Mimetic, Thymidine Kinase by-Pass Nucleoside Prodrug: Radioiodination, in vitro Cellular Uptake and Biodistribution in Murine Models
Current Radiopharmaceuticals Synergistic Enhancement of Cancer Therapy Using a Combination of Fusion Protein MG7-scFv/SEB and Tumor Necrosis Factor Alpha
Protein & Peptide Letters Fighting Fire with Fire: A Patent for the Combined Application of Oncolytic Herpes Viruses and Antiangiogenic Agents in the Battle Against Human Cancers
Recent Patents on Anti-Cancer Drug Discovery The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry An Illustrative Review of Solid Pancreatic Masses: Differential Diagnostic Features of CT and MRI Findings
Current Medical Imaging Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective
Current Medicinal Chemistry Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Current Drug Targets Anti-Inflammatory Iridoids of Botanical Origin
Current Medicinal Chemistry Discovery of 3,4-Diaminocyclobut-3-ene-1,2-dione-Based CXCR2 Receptor Antagonists for the Treatment of Inflammatory Disorders
Current Topics in Medicinal Chemistry Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) The Role of the RhoA/rho-kinase Pathway in Pulmonary Hypertension
Current Drug Discovery Technologies Classical and Innovative Insulin Sensitizing Drugs for the Prevention and Treatment of NAFLD
Current Pharmaceutical Design Recent Advance in the Research of Flavonoids as Anticancer Agents
Mini-Reviews in Medicinal Chemistry The Significance of COX-2 and COX-2 Inhibitors in Liver Fibrosis and Liver Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Proteomic Classification of Breast Cancer
Current Drug Targets Dendritoma Vaccine for Cancer: A Hopeful Approach
Current Cancer Therapy Reviews